For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 42,082 | |||
| General and administrative | 33,164 | |||
| Total operating expenses | 75,246 | |||
| Loss from operations | -75,246 | |||
| Interest income | 6,336 | |||
| Other income, net | 260 | |||
| Total other income, net | 6,596 | |||
| Loss before income taxes | -68,650 | |||
| Net loss | -68,650 | |||
| Adjustment of redeemable noncontrolling interest | 831 | |||
| Accretion of redeemable noncontrolling interest to redemption value | -4,868 | |||
| Deemed dividend on extinguishment of noncontrolling interest and redeemable noncontrolling interest | 36,402 | |||
| Net loss attributable to class a ordinary shareholders of zura | -99,353 | |||
| Basic EPS | -1.06 | |||
| Diluted EPS | -1.06 | |||
| Basic Average Shares | 94,160,138 | |||
| Diluted Average Shares | 94,160,138 | |||
Zura Bio Ltd (ZURA)
Zura Bio Ltd (ZURA)